California Cancer Reporting System Standards, Volume III

CS Mets at Dx-Bone

identifiers

OWNER

AJCC

DESCRIPTION

This data item identifies the presence of distant metastatic involvement of bone at time of diagnosis. The presence of metastatic bone disease at diagnosis is an independent prognostic indicator, and it is used by Collaborative Staging to derive TNM-M codes and SEER Summary Stage codes for some sites.

leveLS

Tumors, Admissions

LENGTH

1

ALLOWABLE VALUES

er1038 CS Mets at Dx-Bone (2010)

See the most current version of the Collaborative Stage Data Collection System (http://cancerstaging.org) for rules and site-specific codes and coding structures.

SOURCE

See CS Version Derived.

uPDATE

Tumor Level

New Case Consolidation

If all of these conditions are true:

• Any of these conditions are true:

• the admission’s Date of Diagnosis year is 2010-2015

• the tumor’s Date of Diagnosis year is 2010-2015

• the tumor’s Date of Diagnosis year is blank AND the admission’s Date of 1st Contact year is 2010-2015

• the admission’s Date of Diagnosis year is blank AND the admission’s Date of 1st Contact year is 2010-2015

• the admission's CS value is NOT blank

• the admission and tumor’s CS values are different

Then list for review

Manual Change

Admission Level

Manual Change or Correction Applied

CONSOLIDATED DATA EXTRACT

Yes

INTERFIELD EDITS

IF385 CS Items, Type Reporting Source-DCO

IF846 CS Mets at DX, Rectum Schema (CS)

IF848 CS Mets at DX, Colon Schema (CS)

IF850 CS Mets at DX--Bone, CS Mets at DX

IF878 CS Items - SEER Required - Non-SSF (CS)

IF1104 CS Mets at DX-BBLL, LymphomaOcularAdnexa

IF1105 CS Mets at DX-BBLL, MycosisFungoides

INTERRECord EDITS

N/A

historical changes